Skip to content

CPAP vs AutoCPAP for Treatment of Obstructive Sleep Apnea (OSA) in the Postoperative Setting

Postoperative Management of Obstructive Sleep Apnea With CPAP vs. an Autoadjusting CPAP Device: a Randomized Controlled Single Center Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00588848
Enrollment
11
Registered
2008-01-09
Start date
2008-01-31
Completion date
2011-04-30
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

Obstructive Sleep Apnea Hypopnea Syndrome, OSA, Postoperative, CPAP

Brief summary

The purpose of this study is to determine if an Autoadjusting CPAP machine is better than the regular CPAP machine in treatment of Obstructive Sleep Apnea in the postoperative setting.

Detailed description

The purpose of this study is to determine if an Autoadjusting CPAP machine is better than the regular CPAP machine in treatment of Obstructive Sleep Apnea in the postoperative setting. Patients with known Obstructive Sleep Apnea who are on CPAP therapy at home and undergo an elective surgery (meeting specified inclusion and exclusion criteria) will be randomized to either using Autoadjusting CPAP vs their usual CPAP at their prescribed settings the night after surgery. During that night, they will be monitored with full polysomnography in their hospital bed.

Interventions

DEVICEAutoadjusting CPAP (VPAP Auto)

An autoadjusting CPAP unit is used in place of subject's own CPAP unit during the night of the polysomnography study (the first night after surgery).

DEVICECPAP

Subject's own CPAP unit is applied to the subject during the polysomnography study night (the first night after surgery)

Sponsors

ResMed
CollaboratorINDUSTRY
Great Lakes NeuroTechnologies Inc.
CollaboratorINDUSTRY
MetroHealth Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Known OSA patients well-controlled by CPAP (not hypoxemic i.e. Oxygen Saturation (SaO2) ≥ 89% and post-treatment Apnea Hypopnea (AHI) \<10) and compliant ( \> 3 hours per night) presenting for elective inpatient surgery to MetroHealth Medical Center 2. Elective extremity or lower abdominal surgery 3. Age \>18 years

Exclusion criteria

1. Surgery that may cause hypoxemia from causes other than the effect on upper airway patency e.g. any thoracic surgery, upper abdominal surgery, head and neck surgery. 2. Surgery on the upper-airway. 3. Any condition that may interfere with application of CPAP mask e.g. trauma, surgery on the face, vomiting, naso-gastric intubation etc. 4. OSA treated with a device other than CPAP e.g. Bilevel positive pressure or V-Positive Airway Pressure 5. OSA needing very high levels of CPAP i.e. \> 16 cms to achieve adequate control 6. OSA or other underlying cardiopulmonary conditions that require supplemental oxygen 7. Patients with decompensated congestive heart failure or advanced Chronic Obstructive Pulmonary Disease (COPD) (FEV1\<35% of predicted) 8. Patients with neuromuscular impairment 9. Patients with central sleep apnea 10. Pregnant patients 11. Decisional impaired subjects who are not able to consent

Design outcomes

Primary

MeasureTime frame
Sleep Related HypoxemiaOn postoperative night number 1 from 2200 to 0600. Study participation will end within 72 hours of admission.

Secondary

MeasureTime frameDescription
Apnea-Hypopnea Index (AHI)On postoperative night number 1 from 2200 to 0600. Study participation will end within 72 hours of admission.Events are defined as apneas and hypopneas. AHI values are typically categorized as 5-14.9 events/hr = mild; 15-29.9 events/hr = moderate; and \>= 30 events/hr = severe
Cardiopulmonary Complications72 hoursPredefined cardiopulmonary complications: Myocardial Infarction, Arrhythmia, new onset Heart Failure, Stroke

Countries

United States

Participant flow

Recruitment details

Only 11 subjects were recruited but only 8 successfully completed the study (3 of the subjects randomized to the use of their usual CPAP slept less than 10 minutes on their night after surgery and thus were excluded from further analysis as the outcomes are based on events during sleep). This resulted in early termination of the study.

Pre-assignment details

No significant events to report.

Participants by arm

ArmCount
AUTOCPAP
An Autoadjusting CPAP unit will be applied to the subject during the 8 hours overnight the first night after surgery (study night) Autoadjusting Continuous Positive Airway Pressure (VPAP Auto) : An autoadjusting CPAP unit is used in place of subject's own CPAP unit during the night of the study (the first night after surgery).
3
CPAP
Subject's own CPAP machine will be applied to the subject during the 8 hours overnight the first after surgery (study night) Continuous Positive Airway Pressure (CPAP) : Subject's own CPAP unit is applied to the subject during the study night (the first night after surgery)
8
Total11

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyPhysician Decision03

Baseline characteristics

CharacteristicCPAPAUTOCPAPTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
8 Participants3 Participants11 Participants
Age, Continuous52.5 years
STANDARD_DEVIATION 7.5
50.3 years
STANDARD_DEVIATION 9
51.2 years
STANDARD_DEVIATION 8.2
Region of Enrollment
United States
8 participants3 participants11 participants
Sex: Female, Male
Female
7 Participants2 Participants9 Participants
Sex: Female, Male
Male
1 Participants1 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 30 / 8
other
Total, other adverse events
0 / 30 / 8
serious
Total, serious adverse events
0 / 30 / 8

Outcome results

Primary

Sleep Related Hypoxemia

Time frame: On postoperative night number 1 from 2200 to 0600. Study participation will end within 72 hours of admission.

Population: 3 of the subjects randomized to the use of their usual CPAP slept less than 10 minutes on their night after surgery and thus were excluded from further analysis as the outcomes are based on events during sleep.

ArmMeasureValue (MEAN)
AUTOCPAPSleep Related Hypoxemia10.5 Percentage of time < 90% saturation
CPAPSleep Related Hypoxemia7.1 Percentage of time < 90% saturation
Secondary

Apnea-Hypopnea Index (AHI)

Events are defined as apneas and hypopneas. AHI values are typically categorized as 5-14.9 events/hr = mild; 15-29.9 events/hr = moderate; and \>= 30 events/hr = severe

Time frame: On postoperative night number 1 from 2200 to 0600. Study participation will end within 72 hours of admission.

Population: 3 of the subjects randomized to the use of their usual CPAP slept less than 10 minutes on their night after surgery and thus were excluded from further analysis as the outcomes are based on events during sleep. Study was terminated early due to enrollment problems.

ArmMeasureValue (MEAN)
AUTOCPAPApnea-Hypopnea Index (AHI)2.1 events per hour
CPAPApnea-Hypopnea Index (AHI)1.2 events per hour
Secondary

Cardiopulmonary Complications

Predefined cardiopulmonary complications: Myocardial Infarction, Arrhythmia, new onset Heart Failure, Stroke

Time frame: 72 hours

Population: None in either group

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
AUTOCPAPCardiopulmonary Complications0 Participants
CPAPCardiopulmonary Complications0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026